GE HealthCare made two AI tools commercially available on Vscan Air SL through Vscan Air Innovation Packages in the US and select countries. Lung Guidance guides probe placement through the standard 8 zone lung protocol with automatic capture and B line scoring, and AutoAS estimates moderate to severe aortic stenosis with a confidence score. Both are FDA 510(k) cleared and CE marked, and existing subscribers are expected to receive them by the end of November 2026.
Our readExtends the Vscan Air AI suite beyond cardiac guidance and Auto EF into lung acquisition and valve disease triage, with vendor validation reporting 95.2 percent diagnostic quality lung exam success for nonexpert users versus 96.8 percent for experts. Buyers should note the tools are SL probe only, sold through a paid Innovation Package, and AutoAS is labeled a diagnostic aid requiring clinician interpretation.